Rahul Bhargava, Director and Head of Hematology, Hematocology, and Stem Cell Transplant at Fortis Health Care, shared a post on LinkedIn:
“Success stories are becoming the norm in lymphoma.
With greater awareness, standardized diagnosis, and the unraveling of genomic pathways, patients today enjoy access to world-class medications and transformative therapies.
Precision treatments are no longer distant dreams—they are realities. From CAR-T cells to BiTE therapies, innovation is lighting the path forward, bringing us closer to victory in the fight against lymphoma.
Join us in this dream world of lymphoma research and treatment— where science, compassion, and innovation come together to create hope, healing, and a brighter future.
Spread the word about our Center of excellence of lymphoma at Fortis Healthcare gurugram.”
More from Rahul Bhargava on OncoDaily.